These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13947127)

  • 41. INVESTIGATIONS IN VITRO ON THE INFLUENCE OF SOME AMOEBAE ON SURVIVAL OF VIRUS POLIOMYELITIS.
    BLAWAT F; KOWALSKA Z
    Biul Inst Med Morsk Gdansk; 1963; 14():15-24. PubMed ID: 14120910
    [No Abstract]   [Full Text] [Related]  

  • 42. [Titration of the virus of tick encephalitis and virus neutralizing antibodies in human embryo fibroblast culture by the phenomenon of interference with poliomyelitis virus].
    AL'TSHTEIN AD
    Vopr Virusol; 1962; 7():529-34. PubMed ID: 14011601
    [No Abstract]   [Full Text] [Related]  

  • 43. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 44. The kinetic of induction of plaque formation in cell monolayers by ribonucleic acid from poliovirus.
    KOCH G
    Experientia; 1960 Nov; 16():490-1. PubMed ID: 13757325
    [No Abstract]   [Full Text] [Related]  

  • 45. Variants of Poliovirus hominis. 2. The association of time of onset of paralysis with particle size.
    DORMAN DC; LARKIN M; PONSFORD J; STANLEY NF
    Aust J Exp Biol Med Sci; 1956 Aug; 34(4):285-92. PubMed ID: 13363760
    [No Abstract]   [Full Text] [Related]  

  • 46. Paralysis after oral poliomyelitis vaccine.
    HINTON GG; DUNCAN IB; RATHBUN JC
    Can Med Assoc J; 1962 Oct; 87(17):915-6. PubMed ID: 13954690
    [No Abstract]   [Full Text] [Related]  

  • 47. [Viral excretion after mass vaccination with attenuated polio virus in Hungary].
    DOEMOEK J; MOLNAR E; JANCSO A
    Offentl Gesundheitsdienst; 1961 Oct; 23():504-6. PubMed ID: 13886900
    [No Abstract]   [Full Text] [Related]  

  • 48. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

  • 49. [VIROLOGICAL RESEARCH ON THE CASES OF POLIOMYELITIS REPORTED IN BELGIUM DURING THE YEARS 1961-1962].
    COURTOIS G; PRINZIE A
    Brux Med; 1963 Oct; 43():1073-89. PubMed ID: 14052967
    [No Abstract]   [Full Text] [Related]  

  • 50. Poliovirus as an antigen.
    STEVENS KM
    J Hyg (Lond); 1957 Dec; 55(4):489-93. PubMed ID: 13491837
    [No Abstract]   [Full Text] [Related]  

  • 51. Variants of Poliovirus hominis. 1. Avirulent variants of types I and III.
    DORMAN DC; PONSFORD J; STANLEY NF
    Aust J Exp Biol Med Sci; 1956 Aug; 34(4):277-84. PubMed ID: 13363759
    [No Abstract]   [Full Text] [Related]  

  • 52. [INHIBITING ACTIVITY IN VITRO OF PYRIMIDINO-GUANIDINE DERIVATIVES ON POLIOMYELITIS VIRUS].
    LODDO B; GARZIA A; FERRARI W
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1542-4. PubMed ID: 14122319
    [No Abstract]   [Full Text] [Related]  

  • 53. Variation in virulence of poliovirus. III. On type III virus by plaque method.
    LI CP; JAHNES WG
    Proc Soc Exp Biol Med; 1958 Jun; 98(2):330-4. PubMed ID: 13554636
    [No Abstract]   [Full Text] [Related]  

  • 54. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 55. [Virological study of paralytic forms of poliomyelitis with fatal outcome].
    MAKSUMOV SS; SARKISIANTS SL
    Med Zh Uzb; 1963 Feb; 2():26-7. PubMed ID: 13932399
    [No Abstract]   [Full Text] [Related]  

  • 56. [The present status of poliomyelitis inoculation with live avirulent polio virus. Report from an information tour].
    BUSER F
    Schweiz Med Wochenschr; 1960 Jan; 90():44-7. PubMed ID: 13806390
    [No Abstract]   [Full Text] [Related]  

  • 57. Antigenic crossings with in poliovirus types.
    MELNICK JL
    Proc Soc Exp Biol Med; 1955 May; 89(1):131-3. PubMed ID: 14384899
    [No Abstract]   [Full Text] [Related]  

  • 58. [BIOSYNTHESIS OF SPECIFIC ANTIGEN IN DISRUPTED CELLS INFECTED WITH POLIOVIRUS RNA].
    DISKINA BS; KIIASHKO AA; MIKHEEVA AV
    Vopr Virusol; 1963; 126():679-88. PubMed ID: 14139251
    [No Abstract]   [Full Text] [Related]  

  • 59. [ON THE LOSS OF NEUTRALIZING PROPERTIES OF POLIOMYELITIS VIRUS IN THE COURSE OF ITS ADSORPTION IN EPITHELIAL KIDNEY CELLS OF M. RHESUS].
    LANGE A; ZUR HAUSEN
    Z Hyg Infektionskr; 1964 Dec; 150():179-84. PubMed ID: 14335617
    [No Abstract]   [Full Text] [Related]  

  • 60. MIRKOVIC RR: Studies on poliomyelitis in Serbia. I. Survey of neutralizing antibodies to polio virus in Serbia in 1954, and isolation of virus 1952-1954.
    MILOVANOVIC MV
    Acta Med Iugosl; 1960; 14():446-65. PubMed ID: 13770993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.